HIMS:NYE-Hims Hers Health Inc (USD)

COMMON STOCK | Household & Personal Products |

Last Closing

USD 22.15

Change

0.00 (0.00)%

Market Cap

USD 4.05B

Volume

6.35M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-19 )

Largest Industry Peers for Household & Personal Products

Symbol Name Price(Change) Market Cap
UL Unilever PLC ADR

N/A

USD 156.46B
KMB Kimberly-Clark Corporation

N/A

USD 48.97B
CHD Church & Dwight Company Inc

N/A

USD 25.54B
CLX The Clorox Company

N/A

USD 20.03B
COTY Coty Inc

N/A

USD 6.68B
ELF ELF Beauty Inc

N/A

USD 6.10B
SPB Spectrum Brands Holdings Inc

N/A

USD 2.56B
EPC Edgewell Personal Care Co

N/A

USD 1.76B
PZC PIMCO California Municipal Inc..

N/A

USD 0.63B
YSG Yatsen Holding

N/A

USD 0.38B

ETFs Containing HIMS

EDOC:LSE Global X Telemedicine & D.. 4.41 % 0.00 %

N/A

USD 3.73M
EDOC:SW Global X Telemedicine & D.. 4.40 % 0.00 %

N/A

N/A
EDOG:LSE Global X Telemedicine & D.. 4.32 % 0.00 %

N/A

USD 0.38M
EDOC:AU BetaShares Digital Health.. 4.23 % 0.00 %

N/A

N/A
FDOC:LSE Fidelity Digital Health U.. 3.43 % 0.00 %

N/A

USD 3.08M
IBUY Amplify Online Retail ETF 3.30 % 0.65 %

N/A

USD 0.16B
XHS SPDR® S&P Health Care Se.. 2.60 % 0.35 %

N/A

USD 0.08B
PSC Principal U.S. Small-Cap .. 0.78 % 0.38 %

N/A

USD 0.66B
FFTY Innovator IBD® 50 ETF 0.00 % 0.80 %

N/A

N/A
RTWO:LSE L&G Russell 2000 US Small.. 0.00 % 0.00 %

N/A

USD 0.15B
RTWP:LSE Legal & General UCITS ETF.. 0.00 % 0.00 %

N/A

USD 0.15B
ETLZ:XETRA L&G Russell 2000 US Small.. 0.00 % 0.00 %

N/A

USD 0.09B

Market Performance

  Market Performance vs. Industry/Classification (Household & Personal Products) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 148.88% 82% B 94% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 148.88% 82% B 94% A
Trailing 12 Months  
Capital Gain 269.17% 82% B 95% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 269.17% 82% B 95% A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 26.03% 88% B+ 86% B+
Dividend Return 26.03% 76% C+ 85% B
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 67.78% 12% F 13% F
Risk Adjusted Return 38.41% 47% F 55% F
Market Capitalization 4.05B 54% F 75% C

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.